On August 3, 2022 Quanterix Corporation (NASDAQ: QTRX), a company expanding the limits of exploration with ultrasensitive biomarker detection, reported that President and Chief Executive Officer Masoud Toloue will present at the Canaccord Genuity 42nd Annual Growth Conference on Wednesday, August 10, 2022 at 1:30 p.m. ET in Boston, MA (Press release, Quanterix, AUG 3, 2022, View Source [SID1234617418]). Toloue will also host one-on-one and group meetings with institutional investors that day.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live webcast of the conversation will be available on the Investors section of the Quanterix website at View Source Replays of the webcast will be available on the Quanterix website for 90 days following the conference.